Education
About Us
Working with TipRanks
Follow Us
Histogen Inc. (HSTOQ)
OTHER OTC:HSTOQ
HSTOQ Stock Chart & Stats
$0.01
<$0.01(0.18%)
At close: 4:00 PM EST
$0.01
<$0.01(0.18%)
Day’s Range― - ―
52-Week Range$0.01 - $0.19
Previous CloseN/A
Volume176.00
Average Volume (3M)612.00
Market Cap
$854.00
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta1.10
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.90
Shares Outstanding4,271,759
10 Day Avg. Volume1,295
30 Day Avg. Volume612
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market Cap0.00
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-2.89
Revenue Forecast (FY)$133.43M
HSTOQ FAQ
What was Histogen Inc.’s price range in the past 12 months?
Histogen Inc. lowest stock price was $0.01 and its highest was $0.19 in the past 12 months.
What is Histogen Inc.’s market cap?
Histogen Inc.’s market cap is $854.00.
When is Histogen Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Histogen Inc.’s earnings last quarter?
Currently, no data Available
Is Histogen Inc. overvalued?
According to Wall Street analysts Histogen Inc.’s price is currently Overvalued.
Does Histogen Inc. pay dividends?
Histogen Inc. does not currently pay dividends.
What is Histogen Inc.’s EPS estimate?
Histogen Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Histogen Inc. have?
Histogen Inc. has 4,271,759 shares outstanding.
What happened to Histogen Inc.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Histogen Inc.?
Currently, no hedge funds are holding shares in HSTOQ
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Histogen Inc.
Conatus Pharmaceuticals, Inc. is a biotechnology company, which engages in the development and commercialization of medicines for the treatment of liver diseases. It focuses in development of emricasan, an orally active pan-caspase inhibitor, for the treatment of patients with chronic liver disease, which reduce the activities of human caspases. The company was founded by Alfred P. Spada, Jennifer Giottonini Cayer, and Steven J. Mento on July 13, 2005 and is headquartered in San Diego, CA.
Technical Analysis
Scinai Immunotherapeutics
―
Cyclerion Therapeutics
―
GRI Bio
―
Tao Synergies
―
Dermata Therapeutics
―
Ownership Overview
―
Insiders
―
Mutual Funds
<0.01% Other Institutional Investors
100.00% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---